Scrutinizer''s report of 6th Annual General Meeting of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals held its 6th Annual General Meeting on 29th September 2025 via video conferencing, which concluded in about 22 minutes at 12:52 PM. The company has 767 equity shareholders on record date 19th September 2025, of which 13 attended through video conference (3 from promoter group and 10 from public). All three ordinary resolutions were passed unanimously with 100% votes in favour — (1) adoption of audited financial statements for FY ended 31st March 2025, (2) reappointment of Ms. Saili Jayaram More (DIN: 02691527) as Whole Time Director (retiring by rotation), and (3) appointment of M/s Pragya & Associates as Secretarial Auditor. Out of 85,12,360 total equity shares, 24,65,624 votes (28.97% of outstanding shares) were polled via remote e-voting, with zero votes against any resolution. Scrutinizer Pragya Jain of M/s Pragya & Associates (Indore) oversaw the e-voting process conducted through NSDL.
This is a routine regulatory filing confirming smooth shareholder approval of all agenda items with no dissent. No material impact on stock price expected — all resolutions were standard AGM business including financial statement adoption, director reappointment, and auditor appointment.